0001193125-23-021179 Sample Contracts
50,000,000 REVOLVING CREDIT FACILITY CREDIT AGREEMENT dated as of January 31, 2023 among COLUMBUS HOLDING COMPANY, as Holdings, MADEIRA ACQUISITION CORP., as the Initial Borrower, immediately after giving effect to the Merger, MERIDIAN BIOSCIENCE,...Revolving Credit Facility • February 1st, 2023 • Meridian Bioscience Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledFebruary 1st, 2023 Company Industry JurisdictionREVOLVING CREDIT FACILITY CREDIT AGREEMENT dated as of January 31, 2023 (this “Agreement”), among Columbus Holding Company, a Delaware corporation (“Holdings”), Madeira Acquisition Corp., an Ohio corporation (the “Initial Borrower”) and, immediately after the Merger (as defined below) on the Closing Date (as defined in Section 1.01 [Defined Terms]; capitalized terms used but not otherwise defined in this introductory paragraph and in the recitals below shall have the meanings assigned thereto herein), Meridian Bioscience, Inc., an Ohio corporation, as the surviving entity of the Merger (the “Target”), the Lenders party hereto from time to time, and PNC Bank, National Association, as administrative agent for the Lenders.
Standard Contracts
TERM LOAN CREDIT AGREEMENT dated as of January 31, 2023 among COLUMBUS HOLDING COMPANY, as Holdings, MADEIRA ACQUISITION CORP., as the Initial Borrower, immediately after giving effect to the Merger, MERIDIAN BIOSCIENCE, INC., as the Borrower, THE...Term Loan Credit Agreement • February 1st, 2023 • Meridian Bioscience Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledFebruary 1st, 2023 Company Industry JurisdictionTERM LOAN CREDIT AGREEMENT dated as of January 31, 2023 (this “Agreement”), among Columbus Holding Company, a Delaware corporation (“Holdings”), Madeira Acquisition Corp., an Ohio corporation (the “Initial Borrower”) and, immediately after the Merger (as defined below) on the Initial Closing Date (as defined in Section 1.01; capitalized terms used but not otherwise defined in this introductory paragraph and in the recitals below shall have the meanings assigned thereto herein), Meridian Bioscience, Inc., an Ohio corporation, as the surviving entity of the Merger (the “Target”), the Lenders party hereto from time to time, the Lead Arrangers, the Coordinating Bank and Standard Chartered Bank, as administrative agent for the Lenders.